Merck KGaA operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Merck KGaA with three other
pharmaceutical manufacturers in Europe:
Novo Nordisk As
sales of 122.02 billion Danish Kroner [US$19.53 billion]
of which 84%
was Diabetes and obesity),
of UNITED KINGDOM
(£19.06 billion [US$25.52 billion]
of which 100%
was BioPharmaceuticals), and
Lonza Group AG
based in SWITZERLAND
(5.92 billion Swiss Francs [US$6.52 billion]
of which 70%
Merck KGaA reported sales of 16.15 billion Euro (US$19.25 billion)
December of 2019.
increase of 8.9%
versus 2018, when the company's sales were 14.84 billion Euro.
Sales of Life Science saw an increase
11.0% in 2019, from
6.19 billion Euro to 6.86 billion Euro.